14869.SD105560; dolphin test
cetacean metagenome
ENA-FIRST-PUBLIC
2023-12-18T20:35:34Z
ENA-LAST-UPDATE
2023-12-18T20:35:34Z
External Id
SAMEA115043788
INSDC center name
UCSDMI
INSDC first public
2023-12-18T20:35:34Z
INSDC last update
2023-12-18T20:35:34Z
INSDC status
public
Submitter Id
qiita_sid_14869:14869.SD105560
age_years
43
animal_id
MUU
behavioral_score
not reported
bloodwork
Blood 6/22- WNL
collection date
2020-07-04
collection_timestamp
2020-07-04
completed_study
No
country
USA
cytology
Diverse bacteria pop +++, coltridium ~ 3 per HPF, rare WBC
date
7/4/20
dna_extracted
TRUE
dolphin_name
MUU
duplicate
No
elevation
193
empo_1
Host-associated
empo_2
Host-associated (saline)
empo_3
Animal (saline)
empo_4
Animal distal gut (saline)
env_biome
urban biome
env_feature
research facility
env_material
fecal material
env_package
host-associated
exp_status
Donor_302
exp_study
Clinical Test
fish
Capelin Herring Eulachon Threadfin Squid
fish_all
Eulachon, Capelin, Herring, Threadfin Herring, Squid
geo_loc_name
USA:CA:La Jolla
geographic location (country and/or sea)
USA
host scientific name
Tursiops truncatus
host_age
43
host_age_units
years
host_body_habitat
UBERON:feces
host_body_product
UBERON:feces
host_body_site
UBERON:feces
host_common_name
bottle-nosed dolphin
host_life_stage
adult
host_subject_id
MUU
host_taxid
9739
host_weight
436
host_weight_units
pounds
intervention_category
Donor
latitude
32.5
location
302N
longitude
-117.25
mass_lb
436
medical_notes
Doing well with no current medical issues.
meds
None currently. Previous meds: NPG eye drops (9/1/2019-5/12/2020), tobramycin eye drops (12/6/19-3/17/20), omeprazole (2/10/2020-2/25/20), sucralfate (2/11-3/16/20)
original_barcode_name
SD105560
phase
One
physical_specimen_location
UCSD
physical_specimen_remaining
FALSE
qiita_sample_type
dolphin fecal material
sample name
qiita_sid_14869:14869.SD105560
sample_number
Baseline 1
sample_timepoint
Baseline
sample_type
dolphin fecal material
scientific_name
cetacean metagenome
sex
female
status
Donor
treatment_group
Donor
treatment_group_2
Donor